20250228861. Cancer Treatments Using Mta-coopera (AMGEN .)
Cancer Treatments Using MTA-Cooperative PRMT5 Inhibitors
Abstract: described herein are methods of treating cancer in a patient comprising administering a prmt5 inhibitor. also provided are methods of treating cancer in a patient comprising administering a prmt5 inhibitor and a standard of care therapy.
Inventor(s): Brian Belmontes, Edward Lau Yue Chan, Paul E. Hughes, Katherine Slemmons, Jan Sun
CPC Classification: A61K31/5377 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))
Search for rejections for patent application number 20250228861